NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/11/2025
Back to search
Official data from USPTO
INSTACAR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
INSTACAR
ST13
US500000097790097Class
40, 42, 44
Filing
97790097
Registration
8024071
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
11/12/2025
Trademark type
Word
Nice classes
40, 42, 44
Filing date
02/10/2023
Registration date
11/11/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/11/2025
Last transaction
11/12/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/22/2025
First use in commerce
04/22/2025
Drawing code
4
Owner type
03
Owner location
Rockville, MD
Examiner
TANNER,MICHAEL R
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Innovative Cellular Therapeutics, Inc.
Representatives
Rhett V. Barney LEE & HAYES, PC
Technical classification
Nice Classes
Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Cryopreservation of human blood and tissue
Class 42
Immunotherapy services namelyresearch and development in the field of cell-based immunotherapy; collection and preservation of biological tissuebloodcellscell culture services for scientific research purposes for others; scientific medical diagnostic servicesBlood analysis for scientific or medical research purposesBlood testing for scientific or medical research purposesCell culture and testing services for scientific and research purposes for others; provision of information and data for diagnosis and medical treatmentproviding medical and scientific research information in the field of cellular therapies; manipulation of cells for therapeutic purposesconducting scientific research and development of gene-based medicines and cellular therapies used for medical treatment purposes; Scientific research in the nature of conducting clinical trials for others in relation to immunotherapy pharmaceutical preparations and drugs for the treatment of cancer and autoimmune diseases; Scientific research in the nature of conducting clinical trials for others in relation to cellular therapy pharmaceutical preparations and drugs for the treatment of genetic disorders and degenerative diseases
Class 44
Medical diagnostic servicesTesting for medical diagnostic or treatment purposes using blood and cell samples; Blood testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical services relating to the removaltreatment and processing of human blood
Publications
History of USPTO decisions and trademark events.
30 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/11/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/22/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/22/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/20/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/16/2025
IUAF
USE AMENDMENT FILED
05/13/2025
EISU
TEAS STATEMENT OF USE RECEIVED
05/13/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/26/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/01/2024
PUBO
PUBLISHED FOR OPPOSITION
10/01/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/11/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/29/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/22/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/22/2024
ALIE
ASSIGNED TO LIE
07/22/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/02/2024
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
02/02/2024
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
02/02/2024
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
02/02/2024
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
02/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/29/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/28/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/28/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/08/2023
GNRT
NON-FINAL ACTION E-MAILED
11/08/2023
CNRT
NON-FINAL ACTION WRITTEN
11/08/2023
DOCK
ASSIGNED TO EXAMINER
11/08/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/01/2023
NWAP
NEW APPLICATION ENTERED
02/14/2023
Continuous trademark protection
Get notified about every new filing that threatens INSTACAR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.